Our results further indicated that enforced IGF2BP3 expression significantly reduced the ability of BET inhibitors to reduce tumor survival (Supplementary Fig. 6i–k), extend survival time (Supplementary Fig. 6l), and inhibit NETosis (Supplementary Fig. 6m, n). The gene discussed is DNER; the disease is neoplasm.